Abstracts and presentations

(Click on the title to open the abstract / presentation, Right-click on mouse to download)

2009

Capelle L, de Vries AC, Haringsma J, Looman CW, Nagtzaam N, van Dekken H, Borg FT, de Vries R, Kuipers EJ. Serum Levels of Leptin As Marker for Patients At High Risk of Gastric Cancer. DDW 2009; W1887.

Di Mario F, Curlo M, Cavestro GM, Morana E, Savarino V, Rugge M, Cavallaro L G, Guida L, Franzè A. “GastroPanel Test” in the Clinical Outcome of GERD. DDW 2009; S1921.

Di Mario F, Gatta L, Franzé A, Rugge M, Scarpignato C, Dal Bò N, Morana E. Effects of Helicobacter pylori eradication on serum pepsinogen I, II, ratio and gastrin-17 in Italian and immigrant patients. Helicobacter 2009;14(4): 408 (P09.31).

Di Mario F, Guida L, Iori A, Cavallaro LG, Curlo M, Morana E, Venerito M, Malfertheiner P, Scarpignato C, Rugge M, Franzè A. Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage.  DDW 2009; T1979.

Di Mario F, Gatta L, Franzè A, Scarpignato C, Dal Bò N, Guida L. Eradication rate of helicobacter pylori in immigratnt patients compared to Italian patients: Results of a clinical trial. Gut 2009; 58 (Suppl II):A255.

Franzè J, Parodi A, Savarino E, Morana E, Bertelè A, Savarino V, Di Mario F. A comparison between lactose breath test and quick test on duodenal biopsies for lactase deficiency, in patients with self reported lactose intolerance. Gut 2009; 58(Suppl II):A261.

Jolanda F, Parodi A, Savarino E, Morana E, Bertelè A, Savarino V, Di Mario F.A Comparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance. DDW 2009; S2067.

Kanizaj TF, Katiciv M, Colic Cvrlje V, Skurla B, Prskalo M, Mrzljak A, Naumovski Mihailic S. Correlation of serological markers with atrophic gastritis and intestinal metaplasia histopathological finding before and after Helicobacter pylori eradication therapy. Gut 2009; 58 (Suppl II):A109.

Kim N, Eshmuratov A, Nah J C.  The Correlation of Endoscopic and Histological Diagnosis of Gastric Atrophy. DDW 2009; T1074

Lee JH, Song HJ, Choi K-S, Kim DH, Choi KD, Lee GH, Jung H-Y, Kim J-H. Performance and Clinical Implications of Serum Pepsinogen I in Patients Undergoing Endoscopic Mucosectomy Due to Early Gastric Tumors. DDW 2009; W1820.

Linderborg K, Marvola T, Marvola M, Salaspuro M, Färkkilä M, Väkeväinen S. Eliminating carcinogenic acetaldehyde from achlorhydric stomach with cysteine.  Gut 2009; 58 (Suppl II):A61.

McNicholl AG, Gisbert JP. Accuracy of GastroPanel for Non Invasive Diagnosis of Atrophic Gastritis. DDW 2009; M1055.

Melnikova E, Maev I , Kashin S, Nadezhin A, Kryokova T, Shubin L. Usefullness of non-invasive detection of H.pylori –associated gastric precancerous conditions and early gastric cancer (EGC). Gut 2009; 58 (Suppl II): A109.

Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Persson C, Shakeri R, Abnet CC, Kamangar F, ISlami F, Dawsey SM, Boffetta P, Engstrand L, Malekzadeh R, Ye W. Effect of clinical use of proton pump inhibitors on serum level of gastrin-17, pepsinogen I, and pepsinogen II. Gut 2009; 58(Suppl II); A273.

Purveeva KV, Konkov M, Sclanckaya, Lapina T. Ivashkin V.The histological dynamics and serum levels of pepsinogen I, II and gastri.-17 in atrophic gastritis after Helicobacter pylori’s eradication. Gut 2009; 58 (Suppl II):A257.

Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova  VA. Pepsinogen I levels and Helicobacter pylori in Siberian populations. Helicobacter 2009;14(4): 337(P01.01).

Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Pylenkova ED. Symptoms of gastroesophageal reflux in the population: association with serum biomarkers. Helicobacter 2009;14(4): 366 (P05.17)

Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Serum Biomarkers of atrophic gastritis in multiethnic population. Gut 2009; 58 (Suppl II);A278

McNicholl AG, Forne M, Barrio J, de la Coba C, Gonzalez B, Rivera R, Esteve M, Fernandez-Bañares F, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM,  Bory F, Rosinach M, Loras C,  Esteban C, Santolaria S, Gomollon F, Valle J,  Gisbert JB. On behalf of the H. pylori Study Group of the Asociación Española Gastroenterología (AEG). Accuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2009;14(4):315-316 (W1.5)

Venerito M , Kohrs S , Wex T, Mönkemüller K,  Schubert D, Adolf  D, Malfertheiner P. Helicobacter Pylori Infection, Gastric Atrophy and the Risk for Oesophageal Squamous Cell Carcinoma in Germany DDW 2009: W1895

Venerito M, Kohrs S, Wex T, Mönkemüller K, Schubert D, Adolf D, Malfertheiner P. Relationship between Helicobacter pylori infection. Gastric atrophy and the risk of oesophageal squamous cell carcinoma in Germany. Gut 2009; 58 (Suppl II);A13.

2008

Curlo M, Iori A, Guida L, Cavallaro L, Dal Bò N, Rugge M, Franzè A, Di Mario F. Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Helicobacter 2008; 13(5):449.

Demiray E, Yýlmaz Ö, Soytürk M, Bekmen N, Gönen C, Güvenir M, Saðol Ö, Dölek D, Þimþek I. A perspective for the detection of Helicobacter pylori infection by four noninvasive tests. Helicobacter 2008; 13(5): 450-451.

Iori A, Curlo M, Guida L, Cavallaro L, Merli R, Minelli R, Maini A, Bertelè A, Franzè A, Di Mario F. Is H. pylori infection related to body atrophic gastritis in patients affected by Autoimmune Thyroid Diseaes (AITD )? Helicobacter 2008; 13(5):438.

Leja M, Chiu HM, Funka K, Jonaitis L, Kiudelis G, Kupcinskas L, Sudraba A, Tolmanis I, Lin JT. The value of pepsinogen II in the detection of active H.pylori infection. Helicobacter 2008; 13(5):407.

Leja M, Kupcinskas L, Lin J-T, Funka K, Janciauskas D, Sudraba A, Jonaitis L, Ivanauskas A, Chiu H-M. The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology. Gastroenterology 2008; 134(4 suppl11): A478.

McNicholl AG, Forné  M, Barrio J, De la Coba C, González B, Rivera R, Fernandez-Bañares F, Gras-Miralles  B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras-Alastruey C, Esteve-Comas M, Esteban C, Gisbert JP. Accuracy of GastroPanel for non invasive diagnosis of atrophic gastritis. Helicobacter 2008; 13(5): 453.

Myllyniemi M, Hendolin P, Telaranta-Keerie A, Nikulin M, Paloheimo LI, Engstrand L, Sipponen P; New specific Helicobacter pylori IgG ELISA test. Helicobacter 2008; 13(5):472.

Nouvenne A, Maini A, Cavallaro LG, Merli R, Guida L, Morana E, Curlo M, Iori A, Martelli L, Martelli M, Cavestro GM, Pelosini I, Scarpignato C, Franzè A, Di Mario F. Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic of an Agonist of Vanilloid Receptor? Gastroenterology 2008; 134(4 suppl11): A629.

Sipponen P, Härkönen M, Salaspuro M. Näkökulma: Atrofinen gastriitti jää usein liian vähälle huomiolle. Suomen Lääkärilehti 2008; 15 (63):1428-1430a

Stankevich LI. The experience of using GastroPanel  (BIOHIT) in diagnosis and control of the treatment of HP-associated gastritis. Laboratory Medicine 2008; 9: 53-57.

Vauhkonen M, Helske T, Kääriäinen I, Hyvärinen H, Karesvuori S, Paloheimo LI, Sipponen P. Quick test for detection of Helicobacter pylori urease activity in gastric biopsy specimen. Helicobacter 2008; 13(5): 473.

Weck MN, Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Helicobacter 2008:13(5);404.

Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis: 3-, 10- or 20-fold increased risk? Helicobacter 2008; 13(5):413-414.

Yýlmaz Ö, Demiray E, Soytürk M, Perez Perez GI, Saðol Ö, Bekmen N, Þimþek I,  Akpýnar H; The effect of H. pylori eradication on serum pepsinogen I and II levels, gastrin-17 and Helicobacter pylori antibodies in patients with dyspepsia.

2007

Cavallaro L, Minelli R, Iori A, Merli R, Nouvenne A, Maini A.  Bertelè A, Franzè A, Di Mario F.  Usefulness of  “serological gastric biopsy” in patients affected by autoimmune thyroid disease (AITD). Gut 2007; 56(Suppl III):A237.

Hajsheykholeslami A, Rakhshani N, Amirzargar  A, Zendehdel N, Shahidi SM, Nikbin B,  Saeidi S, Massarrat S. SERUM BIOMARKERS PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17 IN FIRST DEGREE RELATIVES OF GASTRIC CANCER PATIENTS: A COMPARATIVE STUDY WITH TOPOGRAPHY AND GRADE OF GASTRITIS.  Gut 2007; 56(Suppl III):A93

Hajsheykholeslami A, Rakhshani N, Shahidi SM, Rafiee R, Azimi K, Mohammadi N, Fakhar R, Babaei M, Tabib SM, Saliminejhad M, Nobakht H, Nasiri J, Dooghaie Moghadam M, Saeidi S, Didehvar R, Zendehdel N, Massarrat S. COURSE OF PANGASTRITIS AND SERUM MARKERS PEPSINOGEN I (PEPI) ,PEPSINOGEN II(PEPII) AND GASTRIN17 (G17) IN FIRST-DEGREE RELATIVES OF GASTRIC CANCER PATIENTS, 2 YEARS AFTER H.PYLORI ERADICATION IN A DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED STUDY. Gut 2007; 56(Suppl III):A93

Kolesnikova E, Chupin I, Nemtsova V. EFFICACY OF SERUM GASTRIN-17, PEPSINOGEN I AND HELICOBACTER PYLORI ANTIBODIES IN NON-ENDOSCOPIC DIAGNOSIS OF MULTIFOCAL ATROPHIC GASTRITIS.Gut 2007; 56(Suppl III); A97

de Korwin JD, Prucha V, Vignaud JMM, Conroy MC, Lozniewski A. NON ENDOSCOPIC DIAGNOSIS OF ATROPHIC GASTRITIS: EVALUATION OF THE GASTROPANEL/GASTROSOFT. Gut 2007; 56(Suppl III):A96.

Paik CN, Chung IS,  Park JM,  Cho YK,  Lee IS, Kim SW, Choi MG. THE RELATION BETWEEN PEPSINOGEN I/II RATIO AND AGE OR UPPER GASTROINTESTINAL DISEASES IN HELICOBACTER PYLORI-POSITIVE AND –NEGATIVE SUBJECTS. Gut 2007; 56 (Suppl III);A89

van Marrewijk CJ, van Oijen  MGH, Laheij RJF, Paloheimo LI, Mujakovic S, Fransen GAJ, Numans ME, de Wit NJ, Muris JWM, Grobbee DE, Knottnerus AJ, Jansen JBM. THE INFLUENCE OF GASTRIC STATUS ON EMPIRICAL DYSPEPSIA TREATMENT SUCCESS. Gut 2007; 56(Suppl III); A196.TMENT SUCCESS. Gut 2007; 56(Suppl III); A196.

Haj-sheykholeslami A, Rakhshani N, Amirzargar A, Zendehdel N, Shahidi S, Nikbin B, Khosravi F, Massarat S. Serum Biomarkers Pepsinogen I, Pepsinogen II and Gastrin-17 in First Degree Relatives of Gastric Cancer Patients: A Comparative Study with Topography and Grade of Gastritis.  Helicobacter 2007; 12(4):465-466 (abstract P167)

Myllyniemi M, Linnala A, Paloheimo LI, Hendolin P, Engstrand L, Perez Perez G, Sipponen P. Improved Specificity of Helicobacter pylori IgA/IgG ELISA over other H.pylori Tests. Helicobacter 2007; 12(4):447

2006

Bautista-Marguez A, Guerrero-Almeida ML, Luqueno-Matrinez V, Mucino-Bermejo J, Ruiz-Palacios GM. Levels of Serum Pepsinogen Correlate with the Immune Response of Helicobacter pylori in a Cohort of Mexican Children. Helicobacter 2006;11(4): 354 (05.25).

Cavallaro LG, Maini A, Nouvenne A, Merli R, Iori V, Cavestro GM, Rugge M, Franzè A,  Di Mario F. Serum Pepsinogen II as a marker of aspirin related gastritis. Gut 2006; Vol 55 (suppl V): A283.

Cavallaro LG, Maini A, Nouvenne A, Merli R, Morana E, Guida L, Iori V, Cavestro GM, Gnocchi A, Franzè A,  Di Mario F. Gastrin-17 (G-17): A Serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of
H. Pylori status. Gut 2006; Vol 55 (suppl V): A267.

Cavallaro LG, Maini A. Nouvenne A, Morana E, Merli R, Venerito M, Iori V, Cavestro GM, Rugge M, Malfertheiner P, Franze A, Di Mario F. Serum Pepsinogen II as a Marker of Both Helicobacter pylori and Acetyl Salicylic Acid-Related Gastritis. Helicobacter 2006;11(4): 395 (12.02).

Cavallaro LG, Merli R, Morana E, Iori V, Bertelè A, Cavestro GM, Colla G,  Nervi G,  Gnocchi A, Franzè A,  Di Mario F. GastroPanel® for detection of atrophic gastritis: The “Parma Model". Gut 2006; Vol 55 (suppl V): A285.

Cavallaro LG, Morana E, Guida L, Liatopoulou S, Moussa AM, Cavestro GM, Franze A, Di Mario F. Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relatioship with Density of the Bacterium, Inflammation, and Atrophy.  Helicobacter 2006; 11(4): 352 (05.21).

Cavallaro LG, Nouvenne A, Maini A, Merli R, Fanigliulo L, Basso D, Plebani M, Iori V, Cavestro GM, Maino M, Nervi G, Franze A, Di Mario F. Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of Gastro-Esophageal Reflux Disease (GERD) independently of H.pylori status. Gastroenterol 2006; Vol 130 (4) (Suppl 2):A-168 (S1168).

Di Mario F, Cavallaro LC, Moussa AM,  Caruana P, Merli R, Maini A, Bertolini S,  Dal B´o N,  Rugge M, Cavestro GM,  Aragona G,  Plebani M,  Franz´e A,  Nervi G. Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: RelationshipWith Inflammation, Activity, and Density of the Bacterium. Dig Dis Sci 2006; 51:1791–1795.

Figura N, De Apollonia L, De Marco L,  Santucci A, Canzonieri, Serraino D, Nuti R, Campagna S, Gonnelli C, Lezi C, Sozzi M.  Increased Amidated Gastrin-17 (PGL) Systemic Levels and Gastric Epithelial Cell Proliferation (GECP) in Dyspeptic Patients with CagA-Positive (CagA+) Helicobacter pylori Infection. Helicobacter 2006;11(4): 335 (03.17).

Guariso G, Basso D, Fasolo M, Conte S, Tasinato A, Navaglia F, Fogar P, Zambon CF, Grego E, Schiavon S, Plebani M. GastroPanel: A Useful Screening Test in Pediatric Populations. Helicobacter 2006;11(4): 374 (09.07).

Haj-Sheykholeslami A, Amirzargar A, Saeidi S, Rakhshani N, Nikbin B, Khosravi F, Ansaripour B, Moradi B, Massarrat S. Pepsinogen I and II and Gastrin 17 as Markers of different types and rades of gastritis. Gut 2006; Vol 55 (suppl V): A86.

Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L. Meurman JH, Salaspuro M.  Acetaldehyde production from ethanol by oral Viridans Streptococci.  Presentation at the 11th International Congress on Oral Cancer (ICOOC) May 14-17 2006 in Grado, Italy.

Linderborg K, Salaspuro M. Effect of acetaldehyde concentration in alcoholic beverages on salivary acetaldehyde. Presentation at the 11th International Congress on Oral Cancer (ICOOC) May 14-17 2006 in Grado, Italy.

Moenkemueller K, Peitz U, Wex T, Jaspersen D, Labenz J, Meyer-Sabellek W, Willich SN, Stolte M, Lind T, Malfertheiner P. Pepsinogen I correlates with severe esophagistis and Barrett’s esophagus.Gastroenterol 2006; Vol 130 (4) (Suppl 2):A-390 (M1994).

Nouvenne A, Cavallaro LG, Maini A, Bertele A, Cavestro GM, Franze A, Di Mario F. Gastrin-17: The Key in Order to Understand Relationship between Helicobacter pylori and Gastroesophageal Reflux Disease. Helicobacter 2006;11(4): 356 (06.07).

Orlandi M, Netzer P, Inauen W. Identifying Lactose Intolerance with a novel biopsy-based rapid lactase test. Gut 2006; Vol 55 (suppl V): A98.

Ruiz Palacios y Santos GM, Luqueno V, Bautista Marguez A, Mucino Bermenjo J. Relation between the Pattern of Serum Pepsinogen Changes and the Magnitude of the Immune Response to Helicobacter pylori Infection in a Cohort of Young Mexican Children. Helicobacter 2006;11(4): 353 (05.22).

Salaspuro V, Kaihovaara P , Salaspuro M. Eliminating carcinogenic acetaldehyde from mild alcohol and dietary products with cysteine supplement. Presentation at the 11th International Congress on Oral cancer (ICOOC) May 14-17 2006 in Grado, Italy.

Sipponen P. Diagnosis of Atrophic Gastritis with Plasma Biomarkers. Presentation at  the 6th Western Pacific Helicobacter Congress 12.-14.11.2006, Bangkok, Thailand. Helicobacter 2006; 11(2): 2-3.

Valle J,  López-Pardo R, Rodriguez-Merlo R, Pérez-Grueso M, Artaza T, Alcántara M, García-Vela A, Carrobles J. Validity of a combination of Pepsinogen I and II, 17-Gastrin and Helicobacter Pylori antibodies (GASTROPANEL) for the serologic diagnosis of gastric atrophy. Gut 2006; Vol 55 (suppl V): A92.

Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H. Gastric Corpus Athophy and Without Evidence of Helicobacter pylori Infection. Helicobacter 2006;11(4): 357 (06.08).

2005

Cavallaro LG, Bertolini S, Bosi S, Stefani N, Merli R, Liatopoulou S, Maini A, Maino M, Iori V, Cavestro G, Nervi G, Franze' A, Di Mario F.Gastrin-17 (G­17) and Serum Pepsinogen  (SPGI) for Evaluation of Patients with Gastroesophageal Reflux Disease (GERD) Compared to Dyspeptics or Ulcerous.Gut 2005; 54 (Suppl VII):A105.

Cavallaro LG, Mahamat Moussa A, Maini A, Liatopoulou S, Bertolini S, Merli R, Caruana P, Iori V, Maino M, Cavestro G, Nervi G, Colla G, Rugge M, Franze' A, Di Mario F. Accuracy of “Serological Gastric Biopsy” in a Cohort of Dyspeptic Patients. Gut 2005; 54 (Suppl VII) :A99.

Cavallaro LG, Merli R, Liatopoulou S, Franzè I, Maino M, Iori V, Cavestro G, Gnocchi A, Caruana P, Franzè A, Di Mario F. Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients. Helicobacter 2005; 10 (5):503.

Cavallaro LG, Stefani N, Merli R, Liatopoulou S, Maini A, Maino M, Iori V, Cavestro GM, Gnocchi A, Muzzetto P, Franzè A, DiMario F. Serum Pepsinogen II and Gastrin-17 as Markers of NSAIDs Gastropathy. Gut 2005; 54 (Suppl VII) :A117.

Cavallaro L, Stefani N, Merli R, Morana E, Maino M, Iori V, Cavestro G, Bertelè A, Franzè A, Di Mario F. Serum Pepsinogen II & Gastrin-17 as Markers of NSAIDs-gastropathy independently of H. pylori infection. Helicobacter 2005; 10 (5):540.

De Korwin J-D, Prucha V, Lozniewski A, Vignaud J-M, Conroy MC,  Legoedec J. Non endoscopic diagnosis of atrophic gastritis using the GastroPanel/GastroSoft. Presentation at the workshop organised by French Helicobacter Study Group on Jan 28th 2005 in France.

DiMario F, Bertolini S, Cavallaro L.G, Stefani N, Nervi G, Pilotto A. Gastrin-17 (G-17) and Serum Pepsinogen I (sPGI) for Evaluation of Patients With Gastroesophageal Reflux Disease (GERD) Compared To Dyspeptics or Ulcerous. Gastroenterology 2005; 128 (4, Suppl 2).

DiMario F, Cavallaro L.G, Liatopoulou S, Moussa A, Maini A, Bertolini S, Merli R, Dal Bò N, Iori V, Stefani N, Cavestro G.M, Marcucci F, Rugge M, Franzè A. Accurancy of "serological gastric biopsy" in a cohort of dyspeptic patients. Gastroenterology 2005; 128 (4, Suppl 2).

DiMario F, Ingegnoli A, Altavilla N, Cavallaro LG, Bertoloni S, Merli R, Cavestro GM,  Iori V, Maino M, Leandro G, Franzé A. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundamental & Clinical Pharmacology 2005: 19;497-501.

DiMario F,  Moussa AM,  Dal Bo N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Merli R, Franzé A, Rugge M . Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study. J Gastroenterol Hepatol 2005: 20;1661-1666.

El-Zimaity H, Graham D Y, Campos A, Guerrero L, Chavez A, Cardenas V.Improved diagnoses of corpus gastric atrophy. Helicobacter 2005; 10 (5):500.

Koskinen SM, Putkonen P, Ruuska P, Jauhonen PV. Cost Evaluation of GastroPanel in Dyspepsia Patients over 50 Years of Age. Gut 2005; 54 (Suppl VII) :A91.

Makarenka AV, Pimanov SI. The Improvement of antral Histology, Serum Gastrin-17, Pepsinogen-I and Pepsinogen-II Levels after Eradication is Related to Residual Bacterial Load in Patients with Duodenal Ulcer. Gut 2005; 54 (Suppl VII):A9.

Nurgalieva Z.Z, El-Zimaity H.M, Graham D.Y, Campos A, Guerrero L, Chavez A, Opekun A.R, Cardenas V. Gastric Atrophy in North America: Histology Vs. Non-Invase Testing. Gastroenterology 2005; 128 (4, Suppl 2): A-291.

Nurgalieva ZZ, Graham D Y, El-Zimaity H, Campos A, Guerrero L, Chavez A, Opekun AR, Cardenas V. Non-invasive testing for gastric atrophy in North America. Helicobacter 2005; 10 (5):502.

Nurgalieva Z.Z, Opekun A.R, Conner M.E, Graham D.Y. Serum Pepsinogens in the Diagnosis of Acute Helicobacter Pylori Infection. Gastroenterology 2005; 128 (4, Suppl 2): A-562.

Nurgalieva ZZ, Opekun AR, Conner MC, Graham DY. Serum pepsinogens in the diagnosis of acute Helicobacter pylori infection. Helicobacter 2005; 10 (5):519.

Pasechnikov VD, Chukov SZ, Kotelevets SM, Polyakova MB, Chabannaya TA. Serological and Morphological Correlations in H.pylori-associated Gastric Mucosal Pprecancerous Changes. Gut 2005; 54 (Suppl VII) :A130.

Pimanov SI, Makarenka AV Bacterial load after Helicobacter pylori eradication predicts the changes of gastric antral mucosa, serum gastrin-17, pepsinogen-I and pepsinogen-II levels. Helicobacter 2005; 10 (5):502.

Ristimäki A. Investigating molecular mechanisms in cancer cells. Copenhagen 15th-19th of October 2005.

Robles-Jara C, Robles-Medranda C, Parrales J, Armijos R, Suppo J, Landivar B. Correlation of Levels of Pepsinogen I and II, Gastrin-17, and H. pylori  with the endoscopic biopsies of dyspeptic patients. Presentation at the World Congress of Gastroenterology September 12-14 2005, Montreal, Canada.

Storskrubb T, Aro P, Ronkainen J, Talley N, Stolte M, Vieth M, Sipponen P, Agréus  L. Diagnosis of atrophic corpus gastritis by serological biomarkers. Evaluation in a large population sample (The Kalixanda Study). Presentation at the World Congress of Gastroneterology during September 12-14 2005 in Montreal, Canada.

2004

Cavallaro LG, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavestro GM, Iori V, Merli R, Franzè A, Rugge M, DiMario F. Recovery of gastric function after H. Pylori eradication in subjects with body atrophic gastritis: A prospective four years study. Helicobacter 2004; 9 (5): 527 (A06.04).

Cavallaro LG, Moussa AM, Liatopoulou S, Comparato G, Bertolini S, Merli R, Dal Bo N, Maino M, Bosi S, Cavestro GM, Prati B, Nervi G, Rugge M, Franzé A, DiMario F. Accuracy of "serological gastric biopsy" in a cohort of dyspeptic patients. Presentation at the 6th European Bridging Meeting in Gastroenterology, Kaunas, Lithuania, Nov 26-27, 2004.

Chukov SZ, Pasechnikov VD, Kotelevets SM, Mernova VP, Polyakova MB, Mostovov AN. Sensitivity, specificity and the prognostic value of non-invasive detection of stomach mucosal atrophy. Gut 2004; 53(Suppl VI): A124 (MON-G-257). 

De Korwin JD, Prucha V, Lozniewski A, Vignaud JM, Conroy MC, Legoedec J. Non endoscopic diagnosis of atrophic gastritis using the GastroPanel/GastroSoft. Helicobacter 2004; 9: 561.

DiMario F, Moussa AM, Dal Bò N, Caruana P, Cavallaro LG, Aragona G, Cavestro GM, Iori V, Merli R, Bosi S, Venerito M, Colla G, Pilotto A, Franzè A. Recovery of gastric function after H. Pylori eradication in subjects with body atrophic gastritis: A prospective four years study. Gut 2004; 53 (Suppl VI): A293.

Kalach N, Legoedec J, Wann A, Bergeret M, Dupont C, Raymond J. Serum levels of Pepsinogen I, Pepsinogen II and Gastrin-17 In the course of Helicobacter pylori gastritis in paediatrics. Presentation at the WCPGHN 2004.

Kalem KLGB, Lamari Z, Guedouar H, Djennas N, Souilah F, Bouhadef A. Helicobacter Pylori and chronic gastritis in Algerian children. Helicobacter 2004; 9: 553. (A09.14).

Kuokkanen M, Myllyniemi M, Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Karesvuori S, Linnala A, Harkonen M, Jarvela I. A quick test for perendoscopic diagnosis of hypolactasia from postbulbar duodenal biopsy. Gut 2004; 53(Suppl VI): A284 (WED-G-266).

Lynch K, Sellers T, Ennulat D, Schwartz L. Evaluation and use of a human ELISA method for measuring pepsinogen I in monkey serum. Presentation at the AACC annual meeting 2004 in Los Angeles, Ca, USA, July 25-29,2004.

Makarenka A, Pimanov S, Voropaeva A, Voropaev E. High prevalence of Helicobacter pylori infection and multitude of vacAM and vacAs Helicobacter pylori strains in patients with peptic ulce: Study in Belarus. Presented at Gastroenterology Week Freiburg, Oct 16-17, 2004.

Moussa AM, Germana B, Liatopoulou S, Comparato G, Carloni C, Lecis P, Bertiato B, Doglioni C, Aragona G, Cavallaro LG, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Biedo FC, DiMario F, Franzè A. Screening of Gastric Atrophy by GastroPanel in primary care. Gut 2004; 53 (Suppl VI): A 121 (MON-G-241).

Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB Mernova VP.  The  non-invasive diagnosis of precancerous changes of stomach mucosa . Annales Academiae Medicae Bialostocensis, Roczniki Akademii Medycznej w Bialymstoku 2004; 49:66-71.

Pimanov S, Makarenka A, Voropaeva A. Influence of eradication therapy  on serum gastrin-17, pepsinogen-I and Hp-antibodies levels in duodenal ulcer patients with high density if Helicobacter pylori. Presented at Gastroenterology Week Freiburg, Oct 16-17, 2004.

Robles JC, Robles MC, Parrales GJ, Armijos LR, Suppo RJ, Landivar FB. Correlacion de los analisis sericos del pepsinogeno I, II, gastrina 17, anticuerpos anti-H.pylori, con las biopsias en pacientes dispepticos. Presentation at the XIII Ecuadorian Congress of Gastroenterology, Aug 2004.

Suovaniemi O. Aggressiivinen innovointi- ja patentointistrategia, Tie menestykseen ja kansalliseen hyvinvointiimme, 2.2.2004.

Sipponen P, Vauhkonen M, Helske T, Kääriäinen I, Härkönen M. Serum Fasting Level of Gastrin-17 is Low in Patients with Long-Segment Barrett's Esophagus. Gastroenterol / 2004; Vol 126(4) (Suppl 2): A-177 (S1234).

Tamm A, Tein A, Peetsalu M, Sillakivi T, Kirsimägi Ü, Valle J, Peetsalu A. Dependence of serum antibodies (HP-Ab) against Helicobacter pylori colonsation in the gastric corpus and antrum mucosa. Helicobacter 2004; 9 (5): 510-511.

Vauhkonen M, Sipponen P, Helske T, Kääriäinen I, Härkönen M. Low serum gastrin-17 predicts long-segment Barrett’s esophagus. Presentation at the Finnish Medical Exhibition (Lääkäripäivät 2004), Helsinki, Finland, 4-8 Jan 2004.

Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, Wang X, Wang BL, Miao JY, Ding J, Fan DM.Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis 2004;5(1):22-27.

2003

Cavallaro LG, Moussa AM, Caruana P, Merli R, Bertolini S, Iori V, Cavestro GM, Muzzetto P, Liatopoulou S, Dal Bò N, Di Mario F.Oral Sucrose Test and Serum Pepsinogens for Evaluation of H. pylori Chronic Gastritis. Helicobacter 2003; Vol 8(4): 384 (A05.06).

Cavallaro LG, Moussa AM, Caruana P, Merli R, Cavestro GM, Liatopoulou S, Maino M, Iori V, Marcucci F, Corrente V, Franze A, Di Mario F. Diagnosis of H. pylori Gastritis Patterns by Means of GastroPanel. Helicobacter 2003; Vol 8(4): 383 (A05.05).

Cavallaro L, Moussa AM, Merli R, Bertolini S, Iori V, Cavestro GM, Caruana P, Dal Bó N, Aragona G, Fanigliulo L, Comoerato G, Franzé A, Francesco Di Mario. Assesment of H.pylori-related chronic gastritis by means of serum pepsinogens and oral sucrose test. Presentation at the 5th European Bridging Meeting in Gastroenterology, Bratislava, Slovak Republic, Nov 28-29, 2003.

Cavallaro L, Moussa AM, Merli R, Iori V, Cavestro GM, Cerati E, Altavilla N, Dal Bo' N, Rugge M, Colla G, Bertele' A, Franze' A, Francesco Di Mario. Serum Pepsinogen II for Early Assessment of Success of H. Pylori Eradication. Gastroenterol 2003; 124 (4)(Suppl 1): A-179 (S1238).

De’ Angelis G, Moussa AM, Fornaroli F, Caruana P, Magiteri B, Merli R, Altavilla N, Cavallaro LG, Cavestro GM, Di Mario F. Clinical Usefulness of GastroPanel (sPGI, sPGII, Gastrin, H.pylori specific lgG) in Assessment of H.pylori Infection in Children. Helicobacter 2003; Vol 8(4): 457 (A15.15).

Di Mario F, Cerati E, Cavallaro L, Cavestro GM, Dal Bo' N, Ribeiro L, Fontana F, Seghini P, Moussa AM, Pilotto A, Franze A. Clinical usefulness of GastroPanel (SPGI, SPGII, Gastrin-17, HP specific IgG) in the Assessment of HP Infection. Gastroenterol 2003; 124 (4)(Suppl 1): A-176 (S1223).

Di Mario F, Moussa AM, Caruana P, Cavallaro LG, Cavestro GM, DalBò N, Iori V, Pilotto A, Leandro G, Franze A, Rugge M. ”Serological Biopsy” in First Degree Relatives of Patients with Gastric Cancer, Affected by Helicobacter pylori. Helicobacter 2003; Vol 8(4): 402 (A07.13).

Di Mario F, Moussa AM, Caruana P, Iori V, Cavestro GM, Cavallaro LG, Dal Bò N, Cannizzaro R, Marcucci F, Muzzetto P, Franzè A, Di Mario F. Evaluation of Gastric Function by Means of Gastropanel (SPGI, SPGII, G-17, IGG-HP) in First Degree Relatives of Patients with Gastric Cancer. Digestive and Liver Disease 2003; 35 (suppl 4): S61.

Ingegnoli A, Ferreri G, Del Rio P, Cerati E, Cavestro GM, Cavallaro LG, Leandro G, Basso D, Plebani M, Sianesi M, Di Mario F. Does Chronic Hypercalcemia Influence Serum Pepsinogen Levels? Gastroenterol 2003; 124 (4)(Suppl 1): A-446 (T903).

Liatopoulou S, Moussa AM, Cavallaro LG, Merli R, Iori V, Aragona G, Cavestro GM, Nervi G, Dal Bo' N, Pilotto A, Franzé A, Di Mario F. Failure of Helicobacter pylori Eradication Therapy: A Comparison of Different Risk Factors (Laboratory vs. Environmental Items). Helicobacter 2003; Vol 8(4): 469 (A16.22).

Moussa AM, Cavallaro LG, Caruana P, Bosi S, Cavestro GM, Campi L, Ingegnoli A, Sereni G, Corrente V, Franze A, Di Mario F. Usefulness of GastroPanel in Different Topography of H. pylori Related Chronic Gastritis. Helicobacter 2003; Vol 8(4): 383 (A05.03).

Moussa AM, Dal Bò N, Caruana P, Cavallaro LG, Aragona G, Liatopolou S, Cavestro GM, Iori V, Merli R, Maini A, Gnocchi A, Pilotto A, Franzé A, Di Mario F. Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a  prospective four years study. Presentation at the 5th European Bridging Meeting in Gastroenterology, Bratislava, Slovak Repuplic, Nov 28-29, 2003.

Moussa AM, Di Mario F, Cavallaro LG, Merli R, Bertolini S, Dalbò N, Aragona G, Iori V, Pilotto A, Leandro G, Cavestro GM, Franzé A. Clinical Usefulness of Serum Pepsinogen II in the Assessment of H. pylori Infection. Helicobacter 2003; Vol 8(4): 479 (A17.02).

Perez-Perez GI, Olivares AZ, Sack R, Hasan K, Saker S, Bardham P, Blaser MJ. Assessment of Acquisition of Helicobacter pylori in Bangladeshi Children by Serologic Methods. Helicobacter 2003; Vol 8(4): 386 (A06.02).

Perez-Perez GI, Portal-Celhay C, Olivares A, Francois F, Bini EJ, Blaser MJ. Evaluation of Helicobacter pylori –Infection and Serum Levels of Pepsinogen I, Pepsinogen II, and PG-I/PG-II Ratio in Different Gastrointestinal Conditions. Presentation at the XXVIII PanAmerican Congress of Digestive Diseases, XV PanAmerican Congress of Digestive Endoscopy, XII Uruguayan Congress of Gastroenterology, GASTRO2003 during 28th September and 4th October 2003 in Punta del Este, Uruguay. Abstract number: 014.

Pimanov SI, Makarenko EV, Voropaeva AV, Matvienko ME, Voropaev EV. Prerequisites for Empirical Eradication Therapy in Patients With Duodenal Ulcer: Study in Belarus. Helicobacter 2003; Vol 8(4):475 (A16.40).

Portal-Celhay C, Perez-Perez GI, Olivares AZ, Francois F, Foo S, Bini E, Blaser MJ. Evaluation of Helicobacter pylori Status and Serum Pepsinogen Levels in Barrett’s Esophagus and Gastric Intestinal Metaplasia. Helicobacter 2003;Vol 8(4): 403 (A07.15).

Redeén S, Petersson F, Borch K. Evaluation Blood Levels of Pepsinogens, Gastrin-17 and H. pylori Antibodies for Diagnosis of Gastritis in a General Population Sample. Helicobacter 2003; Vol 8(4): 399 (A07.03).

Redeén S, Petersson F, Paloheimo L, Borch K. Relations of Circulating Levels of Vitamin B12, Folate and Homocysteine to Gastritis and H. pylori Infection in a Sample of the General Population. Helicobacter 2003; Vol 8(4): 403 (A07.14).

Sebastian S, Hall W, Crotty P, O`Connor H, Buckley M, O`Morain C Jr. Detection of Helicobacter pylori Related Premalignant Lesions at Screening in First Degree Relatives of Gastric Cancer. Helicobacter 2003; Vol 8(4): 400 (A07.07).

Sebastian S, Hall W, Qasim A, McLoughlin R, O`Connor H, Crotty P, Buckley M, O`Morain C Jr. Detection of Premalignant Lesions in First Degree Relatives of Gastric Cancer: Endoscopy or Serodiagnosis? Gastroenterol 2003; 124 (4)(Suppl 1): A-420 (M2126).

Sebastian S, McLouglin R, Hall W, Qasim A, O`Connor H, Buckley M, O`Morain C. Non-Invasive Methods of Diagnosis of Gastric Intestinal Metaplasia – an Observational Case-Control Study. Gastroenterol 2003; 124 (4)(Suppl 1): A-423 (M2142).

Sebastian S, O`Connor H, Crotty P, Buckley M, O`Morain C. Detection H. pylori Related Gastric Intestinal Metaplasia and Atrophy Using Seromarkers. Helicobacter 2003;  Vol 8(4): 424 (A10.20).

Sipponen P, Laxen F, Huotari K, Härkönen M. H.pylori related Atrophic Gastritis is a Common Cause of Low Vitamin B12 and High Homocysteine in Serum in an Elderly Male Population. Helicobacter 2003; Vol 8(4): 398 (A07.01).

Tamm A, Tein A, Peetsalu M, Soplepman J, Sillakivi T, Laja E, Mesila I, Valle J, Peetsalu A. Seerumi H.pylori IgG antikehade (S-Hp AK) sõltuvus mao korpuse ja antrumi limaskesta koloniseeritusest H.pyloriga. Research Conference in Medicine at the Medical Faculty of Tartu University 2003.

2002 

Altavilla N, Moussa AM, Seghini P, Cerati E, Cavallaro LG, Cavestro GM, Dal Bo N, Pilotto A, Cannizzarro R, Maino M, Leandro G, Franze A, Di Mario F. Sucrose Test and Serum Pepsinogens as Markers of Inflammation and Damage in Helicobacter pylori -Related Gastritis. Gut 2002;Suppl II Vol 51: A30.

Cavallaro LG, Moussa AM, Seghini P, Aragona G, Iori V, Cavestro GM, Dal Bo N, Pilotto A, Di Mario F. Topoghraphy of Gastric Damage in H. pylori Infection: Evaluation by Serum Pepsinogen Levels. Gut 2002; Suppl II Vol 51: A30.

Di Mario F, Seghini P, Moussa AM, Iori V, Aragona G, Cavestro GM, Dal Bo N, Maino M, Mantovani N, Ingegnoli A, Pilotto A, Franze A. Influence of Different Epidemiological, Pharmacological and Biological Factors of Serum Pepsinogen Levels. Gut 2002; Suppl II Vol 51: A29.

Ingegnoli A, Moussa AM, Altavilla N, Seghini P, Cerati E, Mantovani N, Aragona G, Caruana P, Cavestro GM, Leandro G, Dal Bo N, Dimario F. Serum Pepsinogens and Sucrose Test in Helicobacter pylori Related Gastritis. Gut 2002; Suppl II Vol 5: A29.

Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R,  Puolakkainen P. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.  Aliment Pharmacol Ther 2002; 16:515-520.

Laheij RJF, Oijen MGH, Paloheimo LI, Jansen JBMJ. Vitamin B12 Deficiency and Gastric Functioning in Patients with Cardiovascular Disease. Gut 2002; Suppl III Vol 51: A152.

Mantovani N, Ingegnoli AV, Maino M, Altavilla N, Seghini P, Cerati E, Carloni C, Cavallaro L, Cavestro MG, Leandro G, Pilotto A, Dal Bò N, Di Mario F. Serum Pepsinogen I and Sucrose Test after Administration of Non-Steroideal Anti-inflammatory Drugs. Gut 2002; 51 (Suppl III) A 313.

Moussa AM, Iori V, Aragona G, Seghini P, Cerati E, Campi L, Cavestro GM, Comparato G, Leandro G, Battaglia G, Dal Bo N, Franze A, DiMario F. Relationship between Direst and Indirect Methods for Diagnosis of H. pylori Infection. Gut 2002; Suppl II Vol 5: A110.

Nicolini G, Zagari R, Pozzato P, Lunadei V, De Luca L, Antonini F, Ricciardiello L, Fossi S, Berretti D, Martuzzi C, Fuccio L, Maltoni S, Sipponen P, Bazzoli F, Roda E. Diagnosis of Atrophic Gastritis Based upon a Combination of Three Non-invasive Tests: Preliminary Results of the Ioiano-Monghidoro Project. 7th National Congress of Digestive Diseases, 1-5 Dec 2001, Bari, Italy. (J Gastroenterol Hepatol 2002; 17 (Suppl): A264).

Sipponen P, Linnala A, Paloheimo LI, Härkönen M, Suovaniemi O. Helicobacter pylori Infection and Related Risks and Diseases – Towards Optimal Diagnostics and Evidence Based Medicine. Presentation at the Gastro 2002, St. Petersburg, Russia, 17-20 Sept 2002.

Sipponen P, Linnala A, Väänänen H, Rasmussen, Tunturi-Hihnala H, Sotka M, Turunen M, Sandström R, Heiskanen I, Härkönen M, Suovaniemi O. Helicobacter Pylori Infection and Related Risks and Diseases - Towards Optimal Diagnostics and Evidence Based Medicine. Presentation at the 5th Nordic-Baltic Congress on Infectious Diseases, 22-25 May 2002, Saint-Petersburg, Russia.

Sipponen P, Linnala A, Suovaniemi O, Härkönen M. Non-endoscopic diagnosis of atrophic gastritis by using blood test. Presentation at the Fourth Western Pacific Helicobacter Congress in Perth, Western Australia, March 2002.

Sipponen P, Koskenpato J, Sotka M, Sandström R, Turunen M, Väänänen H, Tunturi-Hihnala H, Rasmussen M, Sande N, Suovaniemi O, Härkönen M. Value of the Test Panel Composing of Serum Assays of Pepsinogen I, Gastrin-17 and H. pylori Antibodies in Non-Endoscopic Diagnosis of Gastritis and Atrophic Gastritis. A Preliminary Prospective Study. Presentation at the World Congress of Gastroenterology, Bangkok, Thailand Feb 24 - March 1, 2002.

Sipponen P, Suovaniemi O, Härkönen M. Non-endoscopic diagnosis of atrophic gastritis by blood test. Presentation at the International Congress of the Middle-East and African Gastroenterologists Association in Amman, Jordan, 28-31 Aug 2002.

Zagari R, Nicolini G, Casaniva S, Fiocca R, Pozzato P, Lunedei V, Di Marco M, De Luca L, Ricciardello L, Martuzzi C, Fuccio L, Maltoni S, Grigioni W, Panuccio D, Sipponen P, Roda E, Bazzoli F. Diagnosis of Atrophic Gastritis in the General Population Based upon a Combination of Three Non-Invasive Tests. Gut 2002; Suppl II Vol 51: A39. 

2001